Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-04-26
2005-04-26
Weddington, Kevin E. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S236200, C514S415000, C514S652000, C514S682000, C514S714000, C514S724000, C514S743000
Reexamination Certificate
active
06884797
ABSTRACT:
Pharmaceutical formulation, its method of preparation, and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethyl sulfoxide; a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used to treat horses infected with Sarcocystis protozoal infections.
REFERENCES:
patent: 4837399 (1989-06-01), Baker et al.
patent: 4983637 (1991-01-01), Herman
patent: 5260342 (1993-11-01), Herman
patent: 5270344 (1993-12-01), Herman
Jackson Walker L.L.P.
Weddington Kevin E.
LandOfFree
Targeted oxidative therapeutic formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted oxidative therapeutic formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted oxidative therapeutic formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3416679